HealthEquity, Inc. (NASDAQ:HQY) Stake Increased by Zurcher Kantonalbank Zurich Cantonalbank

Zurcher Kantonalbank Zurich Cantonalbank lifted its position in shares of HealthEquity, Inc. (NASDAQ:HQY - Free Report) by 28.5% during the third quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 22,526 shares of the company's stock after purchasing an additional 4,993 shares during the period. Zurcher Kantonalbank Zurich Cantonalbank's holdings in HealthEquity were worth $1,844,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also made changes to their positions in the company. GSA Capital Partners LLP acquired a new stake in shares of HealthEquity during the third quarter worth about $638,000. Vaughan Nelson Investment Management L.P. increased its holdings in shares of HealthEquity by 36.7% in the third quarter. Vaughan Nelson Investment Management L.P. now owns 843,423 shares of the company's stock valued at $69,034,000 after purchasing an additional 226,563 shares during the period. Natixis Advisors LLC raised its stake in shares of HealthEquity by 29.8% during the third quarter. Natixis Advisors LLC now owns 209,175 shares of the company's stock worth $17,122,000 after purchasing an additional 48,009 shares during the last quarter. Oppenheimer Asset Management Inc. increased its stake in HealthEquity by 29.4% in the 2nd quarter. Oppenheimer Asset Management Inc. now owns 64,214 shares of the company's stock valued at $5,535,000 after buying an additional 14,573 shares during the period. Finally, Diversify Wealth Management LLC purchased a new position in HealthEquity during the 2nd quarter worth $8,182,000. 99.55% of the stock is owned by hedge funds and other institutional investors.

HealthEquity Trading Down 2.1 %

HealthEquity stock traded down $2.15 during trading on Thursday, hitting $100.85. The company's stock had a trading volume of 529,445 shares, compared to its average volume of 624,564. The stock's fifty day moving average is $92.02 and its 200 day moving average is $83.44. HealthEquity, Inc. has a 1-year low of $62.10 and a 1-year high of $105.82. The stock has a market capitalization of $8.81 billion, a price-to-earnings ratio of 84.04, a P/E/G ratio of 1.59 and a beta of 0.55. The company has a debt-to-equity ratio of 0.51, a quick ratio of 4.10 and a current ratio of 4.10.

HealthEquity (NASDAQ:HQY - Get Free Report) last released its earnings results on Tuesday, September 3rd. The company reported $0.66 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.50 by $0.16. The firm had revenue of $299.93 million during the quarter, compared to the consensus estimate of $284.48 million. HealthEquity had a net margin of 9.61% and a return on equity of 9.01%. As a group, equities research analysts predict that HealthEquity, Inc. will post 2.27 EPS for the current year.

Analyst Upgrades and Downgrades

A number of equities research analysts recently commented on the stock. JMP Securities restated a "market outperform" rating and issued a $105.00 price objective on shares of HealthEquity in a research report on Wednesday, September 4th. BTIG Research lifted their price target on HealthEquity from $110.00 to $130.00 and gave the company a "buy" rating in a research note on Thursday, November 14th. Bank of America raised their target price on HealthEquity from $100.00 to $120.00 and gave the company a "buy" rating in a report on Wednesday, November 13th. Royal Bank of Canada reaffirmed an "outperform" rating and set a $92.00 price target on shares of HealthEquity in a research note on Wednesday, September 4th. Finally, Mizuho initiated coverage on shares of HealthEquity in a research report on Wednesday. They set an "outperform" rating and a $126.00 target price on the stock. One analyst has rated the stock with a hold rating and thirteen have given a buy rating to the company's stock. Based on data from MarketBeat, the company currently has a consensus rating of "Moderate Buy" and a consensus target price of $109.64.

Insider Activity

In other HealthEquity news, Director Frank Corvino sold 1,039 shares of the business's stock in a transaction dated Wednesday, November 6th. The stock was sold at an average price of $96.10, for a total transaction of $99,847.90. Following the transaction, the director now owns 3,784 shares in the company, valued at $363,642.40. The trade was a 21.54 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, Director Robert W. Selander sold 8,250 shares of the company's stock in a transaction dated Wednesday, October 9th. The stock was sold at an average price of $82.98, for a total value of $684,585.00. Following the completion of the sale, the director now directly owns 54,719 shares of the company's stock, valued at $4,540,582.62. The trade was a 13.10 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 10,536 shares of company stock valued at $884,517 in the last ninety days. Company insiders own 2.20% of the company's stock.

HealthEquity Company Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.